Connect with us
[ad_1] The omicron sublineages named BQ.1 and BQ.1.1 continued to spread in the U.S. in the week through Oct. 29, accounting for 27.1% of new cases...
[ad_1] CNN — It’s shaping up to be a severe season for respiratory syncytial virus infections – one of the worst some doctors say they can...
[ad_1] The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that...
[ad_1] Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130...
[ad_1] The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S.,...
[ad_1] The U.S. faces at least seven different versions of Covid-19 omicron as the nation heads into winter when health officials are expecting another wave of...
[ad_1] A new study has found that the COVID antiviral Paxlovid can interact badly with certain heart medications, raising concerns for patients with cardiovascular risk who...
[ad_1] Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data from a Phase 2/3 clinical trial of their omicron BA.4/BA.5-adapated...
[ad_1] A large number of U.S. COVID deaths could be prevented if patients would take Paxlovid, the antiviral developed by Pfizer PFE, -1.79% that helps reduce...
[ad_1] About half of the American public has heard little or nothing about the new COVID-19 bivalent booster, a new survey by the Kaiser Family Foundation...